Literature DB >> 383922

Timing, results, and complications of mandibular reconstructive surgery: report of 32 cases.

A K Adamo, R L Szal.   

Abstract

Sufficient information concerning the difficulties encountered in reconstructive surgery is rarely provided in the literature. This study, which was performed on 32 patients, points out a high rate of complication; major and minor complications were encountered in 68.8% of the patients. Benign and traumatic lesions caused the fewest problems. Malignant lesions, particularly those receiving radiotherapy, had the greatest incidence of complications. Successful reconstruction was accomplished in 75% of the cases. The use of a corticocancellous autogenous graft is suggested in selected cases of malignant disease.

Entities:  

Mesh:

Year:  1979        PMID: 383922

Source DB:  PubMed          Journal:  J Oral Surg        ISSN: 0022-3255


  4 in total

Review 1.  Reconstruction of Continuity Defects of the Mandible with Non-vascularized Bone Grafts. Systematic Literature Review.

Authors:  Babatunde Olayemi Akinbami
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2016-03-03

Review 2.  Choice of osseous and osteocutaneous flaps for mandibular reconstruction.

Authors:  Akihiko Takushima; Kiyonori Harii; Hirotaka Asato; Akira Momosawa; Mutsumi Okazaki; Takashi Nakatsuka
Journal:  Int J Clin Oncol       Date:  2005-08       Impact factor: 3.402

3.  Osteoradionecrosis of Jaw in Head and Neck Cancer Patient Treated with Free Iliac Bone and Umbilical Fat Pad Graft.

Authors:  Yuri Choi; Su-Gwan Kim; Seong-Yong Moon; Ji-Su Oh; Jae-Seek You; Kyung-In Jeong; Sung-Seok Lee
Journal:  Maxillofac Plast Reconstr Surg       Date:  2014-03-30

4.  Mandibular reconstruction with autogenous non-vascularised bone graft.

Authors:  Ramat Oyebunmi Braimah; Adebayo Aremu Ibikunle; Umar Abubakar; Abdurrazaq Olanrewaju Taiwo; Muhammed Oboirien; Francis Adewale Adejobi; Terry Godwin Ndubuisi; Siddiq Abubakar
Journal:  Afr Health Sci       Date:  2019-09       Impact factor: 0.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.